Adult Acute Myeloid Leukemia — Trials

Adult Acute Myeloid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

374 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 64
Recruiting: 39
Ph III recruiting: 4
Growth YoY: —
Industry share: 17%
Top sponsor: City of Hope Medical Center
Termination share: 36.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (72)

clinicaltrialsPublishedShowing 1–15 of 15 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06533761	Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML	recruiting	Phase 1	125	Stelexis BioSciencesINDUSTRY	2	Aug 25, 2026	clinicaltrials
NCT03017820	A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma	recruiting	Phase 1	99	Mayo ClinicOTHER	1	Jun 10, 2026	clinicaltrials